Are Insurance Leaders Stuck in Silos? New Global Study Reveals Surprising Disconnects

Insurance data analytics meeting

In an era when every professional industry—from insurance and mortgage to real estate and finance—is racing toward smarter, data‑driven decisions, a groundbreaking global survey reveals something unexpected: many insurance companies are still making choices in isolation. The study, conducted by Risk.net and SAS, uncovers that a significant percentage of senior decision‑makers lack confidence in their organization’s ability to connect strategy, technology and real‑time data.

A Closer Look at the Findings

Nearly four in ten leaders surveyed—38%—admit they are not sure their company has a comprehensive, real-time view of risks, revenue and costs. While an encouraging 85% say they have a clear organizational vision, many still operate in fragmented environments where teams, systems and strategies remain disconnected.

The full report, Breaking Silos: Agile Insurance in an Uncertain World, highlights challenges familiar across all sectors: economic uncertainty, regulatory pressure, rapid technological shifts and cost‑management hurdles.

The Data Tells a Bigger Story

41% say poor data quality is the biggest barrier to effective decision‑making.
36% cite lack of collaboration and unclear ownership.
• Over 40% admit claims decisions still rely on gut instinct more than analytics.
• Yet more than 70% in regulatory reporting and financial management say they rely heavily on data‑driven insights.

It’s a layered landscape—one where high expectations collide with siloed or outdated processes. As SAS expert Franklin Manchester notes, AI and analytics can revolutionize operations, but only when backed by a cohesive, organization‑wide strategy.

Where Opportunity Meets Innovation

Despite the obstacles, the insurance industry sits on the edge of major transformation. Leaders interviewed point to the growing potential of AI, machine learning and advanced analytics to elevate data quality, unify decision‑making and modernize how insurers operate.

According to SAS Global Advisor Thorsten Hein, embracing these innovations results in stronger customer satisfaction, heightened efficiency and long‑term financial resilience.

Interested in Digging Deeper?

Professionals can explore these insights via an interactive dashboard or register for the upcoming webinar, Breaking the Insurance Silos: Driving Profitability and Agility, featuring voices from AXA, Bupa Hong Kong, SAS and Deloitte.

Why This Matters to Professionals Across Industries

Whether you’re in insurance, real estate, finance or any other regulated profession, the message is universal: modern professionals must understand data, embrace technology and continually invest in growth to stay competitive.

At Cameron Academy, we see this shift firsthand. Professionals entering or advancing in their field increasingly seek flexible, high‑quality training that keeps them ahead of change. As industries push toward more collaborative, analytics‑driven operations, licensed professionals who understand compliance, data and decision‑making will hold exceptional advantage.

To read the complete press release, visit SAS at this link.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

The Remote Work Revolution: Redefining Real Estate

Imagine a morning where the commute is just a few steps from your bedroom to your home office. This is the reality for many in today's post-pandemic world, where remote work has become a staple of the modern workforce.

By |December 2, 2024|Categories: Article, Real Estate, Remote Work|Tags: , |0 Comments

CRISPR: The Future of Gene Editing and Its Clinical Implications

CRISPR technology has become the frontrunner in genome editing, surpassing earlier methods like zinc finger nucleases and transcription activator-like effector nucleases. The recent FDA approval of the CRISPR-Cas9 drug, exa-cel, marks a significant milestone particularly for treating sickle cell disease and transfusion-dependent beta thalassemia.

By |December 1, 2024|Categories: Article, Biotechnology, Medicine|Tags: , |0 Comments

AI Revolution in Oncology: Transformative Potential or Overhyped?

In recent years, artificial intelligence has emerged as a revolutionary tool in the field of oncology. AI's integration into healthcare transcends buzzwords, transforming cancer diagnosis, treatment personalization, and drug discovery.

AI in Radiology: A Double-Edged Sword

The rapid advancements in artificial intelligence (AI) are transforming the landscape of radiology, promising to enhance diagnostic accuracy and support personalized medicine. However, as this technology becomes more integral to medical imaging, it brings with it a host of ethical and societal considerations that cannot be ignored.

Humanity at the Crossroads: Ethical Implications of AI in Medicine

AI's promise in healthcare is undeniable, with its ability to uncover hidden disease patterns and predict illnesses. However, the reliance on historical data can exacerbate existing biases, particularly affecting marginalized communities such as the LGBTQIA+ and certain ethnic and racial groups.

The Future of Telemedicine: Challenges and Opportunities Beyond the Pandemic

Telemedicine stands out as a transformative force, offering a lifeline to patients and providers alike. As we move beyond the pandemic, the challenge is to integrate this technology without escalating costs or overshadowing the indispensable role of in-person consultations.

By |November 30, 2024|Categories: Article, Healthcare, Technology|Tags: , |0 Comments